THE PROJECT ALS MISSION
Project ALS identifies and funds the most promising scientific research that will lead to the first effective treatments and a cure for ALS. We recruit the world’s best scientists and doctors to work together—rationally and aggressively—to develop a better understanding of the ALS disease process and, in parallel, better therapeutic strategies.
Project ALS is the world’s first ALS organization to focus exclusively on research. We have raised over $110 million in 23 years to fund ALS research programs at leading academic institutions including Harvard University, Columbia University, UCSF, and the Salk Institute, and have made significant progress toward a cure for ALS.
Read about the latest updates in ALS research, and see the Project ALS research philosophy – something we’re proud to say has accelerated the pace of research.
WHAT'S NEW WITH PROJECT ALS
Next Steps for Prosetin
Prosetin is moving to Phase I clinical trials. View the recording of our live conversation with clinical trial specialist Jinsy Andrews, MD, MSc and regulatory
Masitinib Voluntary Hold Reinforces Need for ALS-Focused Drug Development
On June 3rd, AB Science announced that they were putting all clinical studies of their lead compound masitinib—including a Phase 3 trial in ALS—on voluntary
The Hunt for ALS Biomarkers: Fat?
Updated October 2021: Check out new results from Dr. Estela Area-Gomez in Nature Scientific Reports The entire ALS community—patients, researchers, biotechs, doctors, regulators alike—agree on one thing:
